한글목차

만성 신장병(CKD) 치료제 시장은 2024-2029년 40억 7,590만 달러 증가하고, 예측 기간 동안 CAGR 4.9%로 성장할 것으로 예측됩니다.

만성 신장병(CKD) 치료제 시장에 대해 조사 분석했으며, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 포함한 벤더 분석 등의 정보를 전해드립니다.

현재 시장 시나리오, 최신 동향 및 촉진요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 세계 CKD 유병률 증가, 세계 헬스케어 지출 증가, CKD 조기 발견 및 진단의 필요성에 대한 인식 증가가 시장을 주도하고 있습니다.

이 조사는 업계 주요 참가자들의 의견을 포함하여 1차 및 2차 정보를 객관적으로 결합하여 수행되었습니다. 이 보고서에는 주요 기업 분석, 종합적인 시장 규모 데이터, 지역별 분석에 따른 부문, 공급업체 현황이 포함되어 있습니다. 보고서에는 과거 데이터와 예측 데이터가 있습니다.

이 보고서는 향후 몇 년간 만성 신장병(CKD) 치료제 시장의 성장을 촉진하는 주요 요인 중 하나로 CKD 치료제의 승인 건수 증가를 꼽았습니다. 또한, CKD 치료에서 정밀의료의 채택에 대한 관심이 높아지고 CKD 치료의 기술 혁신은 시장의 큰 수요로 이어질 것입니다.

목차

제1장 주요 요약

• 시장 개요

제2장 Technavio 분석

• 가격·수명주기·고객 구입 바스켓·채용률·구입 기준 분석
• 인풋의 중요성과 차별화 요인
• 혼란 요인
• 성장 촉진요인과 과제의 영향

제3장 시장 상황

• 시장 생태계
• 시장 특징
• 밸류체인 분석

제4장 시장 규모

• 시장 정의
• 시장 부문 분석
• 시장 규모 2024
• 시장 전망 2024-2029년

제5장 시장 규모 실적

• 만성 신장병(CKD) 치료제 세계 시장 2019-2023년
• 약물 클래스별 부문 분석 2019-2023년
• 투여 경로별 부문 분석 2019-2023년
• 유통 채널별 부문 분석 2019-2023년
• 지역별 부문 분석 2019-2023년
• 국가별 부문 분석 2019-2023년

제6장 정성 분석

• AI의 영향 : 만성 신장병(CKD) 치료제 세계 시장

제7장 Five Forces 분석

• Five Forces 요약
• 구매자의 교섭력
• 공급 기업의 교섭력
• 신규 참여업체의 위협
• 대체품의 위협
• 경쟁의 위협
• 시장 상황

제8장 시장 세분화 : 약물 종류별

• 시장 부문
• 비교 : 약물 종류별
• ESA : 시장 규모와 예측 2024-2029년
• 칼슘 채널 차단제 : 시장 규모와 예측 2024-2029년
• 인산 결합제 : 시장 규모와 예측 2024-2029년
• ACE 억제제 : 시장 규모와 예측 2024-2029년
• 기타 : 시장 규모와 예측 2024-2029년
• 시장 기회 : 약물 종류별

제9장 시장 세분화 : 투여 경로별

• 시장 부문
• 비교 : 투여 경로별
• 경구 : 시장 규모와 예측 2024-2029년
• 피하 : 시장 규모와 예측 2024-2029년
• 정맥내 : 시장 규모와 예측 2024-2029년
• 시장 기회 : 투여 경로별

제10장 시장 세분화 : 유통 채널별

• 시장 부문
• 비교 : 유통 채널별
• 오프라인 : 시장 규모와 예측 2024-2029년
• 온라인 : 시장 규모와 예측 2024-2029년
• 시장 기회 : 유통 채널별

제11장 고객 상황

• 고객 상황 개요

제12장 지역별 상황

• 지역별 세분화
• 지역별 비교
• 북미 : 시장 규모와 예측 2024-2029년
• 유럽 : 시장 규모와 예측 2024-2029년
• 아시아 : 시장 규모와 예측 2024-2029년
• 세계 기타 지역 : 시장 규모와 예측 2024-2029년
• 미국 : 시장 규모와 예측 2024-2029년
• 중국 : 시장 규모와 예측 2024-2029년
• 독일 : 시장 규모와 예측 2024-2029년
• 인도 : 시장 규모와 예측 2024-2029년
• 영국 : 시장 규모와 예측 2024-2029년
• 캐나다 : 시장 규모와 예측 2024-2029년
• 프랑스 : 시장 규모와 예측 2024-2029년
• 일본 : 시장 규모와 예측 2024-2029년
• 브라질 : 시장 규모와 예측 2024-2029년
• 한국 : 시장 규모와 예측 2024-2029년
• 시장 기회 : 지역 상황별

제13장 촉진요인, 과제, 기회, 억제요인

• 시장 성장 촉진요인
• 시장 과제
• 성장 촉진요인과 과제의 영향
• 시장 기회·억제요인

제14장 경쟁 구도

• 개요
• 경쟁 구도
• 혼란 상황
• 업계 리스크

제15장 경쟁 분석

• 기업 개요
• 기업 순위 지수
• 기업의 시장 포지셔닝
• Abbott Laboratories
• AbbVie Inc.
• Amgen Inc.
• AstraZeneca Plc
• Bayer AG
• Biogen Inc.
• Boehringer Ingelheim International GmbH
• Eli Lilly and Co.
• F. Hoffmann La Roche Ltd.
• Horizon Therapeutics Plc
• Johnson and Johnson Services Inc.
• Novartis AG
• OPKO Health Inc.
• Pfizer Inc.
• Sanofi SA

제16장 부록

영문목차

The chronic kidney disease (CKD) drugs market is forecasted to grow by USD 4,075.9 mn during 2024-2029, accelerating at a CAGR of 4.9% during the forecast period. The report on the chronic kidney disease (CKD) drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of ckd globally, increase in healthcare expenditure globally, and growing awareness about need for early detection and diagnosis of ckd.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's chronic kidney disease (CKD) drugs market is segmented as below:

By Drug Class

• Erythropoietin stimulating agents
• Calcium channel blockers
• Phosphate binders
• ACE inhibitors
• Others

By Route Of Administration

• Oral
• Subcutaneous
• Intravenous

By Distribution Channel

• Offline
• Online

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the growing number of drug approvals for ckd treatment as one of the prime reasons driving the chronic kidney disease (CKD) drugs market growth during the next few years. Also, rising focus on adoption of precision medicine for ckd treatment and technological innovations in ckd treatment will lead to sizable demand in the market.

The report on the chronic kidney disease (CKD) drugs market covers the following areas:

• Chronic Kidney Disease (CKD) Drugs Market sizing
• Chronic Kidney Disease (CKD) Drugs Market forecast
• Chronic Kidney Disease (CKD) Drugs Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading chronic kidney disease (CKD) drugs market vendors that include Abbott Laboratories, AbbVie Inc., Akebia Therapeutics, Amgen Inc., AstraZeneca Plc, Bayer AG, Biogen Inc., Boehringer Ingelheim International GmbH, Eli Lilly and Co., F. Hoffmann La Roche Ltd., Horizon Therapeutics Plc, Johnson and Johnson Services Inc., Novartis AG, OPKO Health Inc., Pfizer Inc., Rockwell Medical Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., and Zydus Lifesciences Ltd.. Also, the chronic kidney disease (CKD) drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Drug Class
  • Executive Summary - Chart on Market Segmentation by Route of Administration
  • Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
  • Overview on criticality of inputs and factors of differentiation
• 2.3 Factors of disruption
  • Overview on factors of disruption
• 2.4 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

• 3.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 3.2 Market characteristics
  • Market characteristics analysis
• 3.3 Value chain analysis
  • Value chain analysis

4 Market Sizing

• 4.1 Market definition
  • Offerings of companies included in the market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2024
• 4.4 Market outlook: Forecast for 2024-2029
  • Chart on Global - Market size and forecast 2024-2029 ($ million)
  • Data Table on Global - Market size and forecast 2024-2029 ($ million)
  • Chart on Global Market: Year-over-year growth 2024-2029 (%)
  • Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

• 5.1 Global Chronic Kidney Disease (CKD) Drugs Market 2019 - 2023
  • Historic Market Size - Data Table on Global Chronic Kidney Disease (CKD) Drugs Market 2019 - 2023 ($ million)
• 5.2 Drug Class segment analysis 2019 - 2023
  • Historic Market Size - Drug Class Segment 2019 - 2023 ($ million)
• 5.3 Route of Administration segment analysis 2019 - 2023
  • Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
• 5.4 Distribution Channel segment analysis 2019 - 2023
  • Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
• 5.5 Geography segment analysis 2019 - 2023
  • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
• 5.6 Country segment analysis 2019 - 2023
  • Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

• 6.1 The AI impact on global chronic kidney disease (CKD) drugs market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2024 and 2029
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2024 and 2029
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2024 and 2029
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2024 and 2029
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2024 and 2029
• 7.7 Market condition
  • Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Drug Class

• 8.1 Market segments
  • Chart on Drug Class - Market share 2024-2029 (%)
  • Data Table on Drug Class - Market share 2024-2029 (%)
• 8.2 Comparison by Drug Class
  • Chart on Comparison by Drug Class
  • Data Table on Comparison by Drug Class
• 8.3 ESA - Market size and forecast 2024-2029
  • Chart on ESA - Market size and forecast 2024-2029 ($ million)
  • Data Table on ESA - Market size and forecast 2024-2029 ($ million)
  • Chart on ESA - Year-over-year growth 2024-2029 (%)
  • Data Table on ESA - Year-over-year growth 2024-2029 (%)
• 8.4 Calcium channel blockers - Market size and forecast 2024-2029
  • Chart on Calcium channel blockers - Market size and forecast 2024-2029 ($ million)
  • Data Table on Calcium channel blockers - Market size and forecast 2024-2029 ($ million)
  • Chart on Calcium channel blockers - Year-over-year growth 2024-2029 (%)
  • Data Table on Calcium channel blockers - Year-over-year growth 2024-2029 (%)
• 8.5 Phosphate binders - Market size and forecast 2024-2029
  • Chart on Phosphate binders - Market size and forecast 2024-2029 ($ million)
  • Data Table on Phosphate binders - Market size and forecast 2024-2029 ($ million)
  • Chart on Phosphate binders - Year-over-year growth 2024-2029 (%)
  • Data Table on Phosphate binders - Year-over-year growth 2024-2029 (%)
• 8.6 ACE inhibitors - Market size and forecast 2024-2029
  • Chart on ACE inhibitors - Market size and forecast 2024-2029 ($ million)
  • Data Table on ACE inhibitors - Market size and forecast 2024-2029 ($ million)
  • Chart on ACE inhibitors - Year-over-year growth 2024-2029 (%)
  • Data Table on ACE inhibitors - Year-over-year growth 2024-2029 (%)
• 8.7 Others - Market size and forecast 2024-2029
  • Chart on Others - Market size and forecast 2024-2029 ($ million)
  • Data Table on Others - Market size and forecast 2024-2029 ($ million)
  • Chart on Others - Year-over-year growth 2024-2029 (%)
  • Data Table on Others - Year-over-year growth 2024-2029 (%)
• 8.8 Market opportunity by Drug Class
  • Market opportunity by Drug Class ($ million)
  • Data Table on Market opportunity by Drug Class ($ million)

9 Market Segmentation by Route of Administration

• 9.1 Market segments
  • Chart on Route of Administration - Market share 2024-2029 (%)
  • Data Table on Route of Administration - Market share 2024-2029 (%)
• 9.2 Comparison by Route of Administration
  • Chart on Comparison by Route of Administration
  • Data Table on Comparison by Route of Administration
• 9.3 Oral - Market size and forecast 2024-2029
  • Chart on Oral - Market size and forecast 2024-2029 ($ million)
  • Data Table on Oral - Market size and forecast 2024-2029 ($ million)
  • Chart on Oral - Year-over-year growth 2024-2029 (%)
  • Data Table on Oral - Year-over-year growth 2024-2029 (%)
• 9.4 Subcutaneous - Market size and forecast 2024-2029
  • Chart on Subcutaneous - Market size and forecast 2024-2029 ($ million)
  • Data Table on Subcutaneous - Market size and forecast 2024-2029 ($ million)
  • Chart on Subcutaneous - Year-over-year growth 2024-2029 (%)
  • Data Table on Subcutaneous - Year-over-year growth 2024-2029 (%)
• 9.5 Intravenous - Market size and forecast 2024-2029
  • Chart on Intravenous - Market size and forecast 2024-2029 ($ million)
  • Data Table on Intravenous - Market size and forecast 2024-2029 ($ million)
  • Chart on Intravenous - Year-over-year growth 2024-2029 (%)
  • Data Table on Intravenous - Year-over-year growth 2024-2029 (%)
• 9.6 Market opportunity by Route of Administration
  • Market opportunity by Route of Administration ($ million)
  • Data Table on Market opportunity by Route of Administration ($ million)

10 Market Segmentation by Distribution Channel

• 10.1 Market segments
  • Chart on Distribution Channel - Market share 2024-2029 (%)
  • Data Table on Distribution Channel - Market share 2024-2029 (%)
• 10.2 Comparison by Distribution Channel
  • Chart on Comparison by Distribution Channel
  • Data Table on Comparison by Distribution Channel
• 10.3 Offline - Market size and forecast 2024-2029
  • Chart on Offline - Market size and forecast 2024-2029 ($ million)
  • Data Table on Offline - Market size and forecast 2024-2029 ($ million)
  • Chart on Offline - Year-over-year growth 2024-2029 (%)
  • Data Table on Offline - Year-over-year growth 2024-2029 (%)
• 10.4 Online - Market size and forecast 2024-2029
  • Chart on Online - Market size and forecast 2024-2029 ($ million)
  • Data Table on Online - Market size and forecast 2024-2029 ($ million)
  • Chart on Online - Year-over-year growth 2024-2029 (%)
  • Data Table on Online - Year-over-year growth 2024-2029 (%)
• 10.5 Market opportunity by Distribution Channel
  • Market opportunity by Distribution Channel ($ million)
  • Data Table on Market opportunity by Distribution Channel ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2024-2029 (%)
  • Data Table on Market share By Geographical Landscape 2024-2029 (%)
• 12.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 12.3 North America - Market size and forecast 2024-2029
  • Chart on North America - Market size and forecast 2024-2029 ($ million)
  • Data Table on North America - Market size and forecast 2024-2029 ($ million)
  • Chart on North America - Year-over-year growth 2024-2029 (%)
  • Data Table on North America - Year-over-year growth 2024-2029 (%)
• 12.4 Europe - Market size and forecast 2024-2029
  • Chart on Europe - Market size and forecast 2024-2029 ($ million)
  • Data Table on Europe - Market size and forecast 2024-2029 ($ million)
  • Chart on Europe - Year-over-year growth 2024-2029 (%)
  • Data Table on Europe - Year-over-year growth 2024-2029 (%)
• 12.5 Asia - Market size and forecast 2024-2029
  • Chart on Asia - Market size and forecast 2024-2029 ($ million)
  • Data Table on Asia - Market size and forecast 2024-2029 ($ million)
  • Chart on Asia - Year-over-year growth 2024-2029 (%)
  • Data Table on Asia - Year-over-year growth 2024-2029 (%)
• 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
  • Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
• 12.7 US - Market size and forecast 2024-2029
  • Chart on US - Market size and forecast 2024-2029 ($ million)
  • Data Table on US - Market size and forecast 2024-2029 ($ million)
  • Chart on US - Year-over-year growth 2024-2029 (%)
  • Data Table on US - Year-over-year growth 2024-2029 (%)
• 12.8 China - Market size and forecast 2024-2029
  • Chart on China - Market size and forecast 2024-2029 ($ million)
  • Data Table on China - Market size and forecast 2024-2029 ($ million)
  • Chart on China - Year-over-year growth 2024-2029 (%)
  • Data Table on China - Year-over-year growth 2024-2029 (%)
• 12.9 Germany - Market size and forecast 2024-2029
  • Chart on Germany - Market size and forecast 2024-2029 ($ million)
  • Data Table on Germany - Market size and forecast 2024-2029 ($ million)
  • Chart on Germany - Year-over-year growth 2024-2029 (%)
  • Data Table on Germany - Year-over-year growth 2024-2029 (%)
• 12.10 India - Market size and forecast 2024-2029
  • Chart on India - Market size and forecast 2024-2029 ($ million)
  • Data Table on India - Market size and forecast 2024-2029 ($ million)
  • Chart on India - Year-over-year growth 2024-2029 (%)
  • Data Table on India - Year-over-year growth 2024-2029 (%)
• 12.11 UK - Market size and forecast 2024-2029
  • Chart on UK - Market size and forecast 2024-2029 ($ million)
  • Data Table on UK - Market size and forecast 2024-2029 ($ million)
  • Chart on UK - Year-over-year growth 2024-2029 (%)
  • Data Table on UK - Year-over-year growth 2024-2029 (%)
• 12.12 Canada - Market size and forecast 2024-2029
  • Chart on Canada - Market size and forecast 2024-2029 ($ million)
  • Data Table on Canada - Market size and forecast 2024-2029 ($ million)
  • Chart on Canada - Year-over-year growth 2024-2029 (%)
  • Data Table on Canada - Year-over-year growth 2024-2029 (%)
• 12.13 France - Market size and forecast 2024-2029
  • Chart on France - Market size and forecast 2024-2029 ($ million)
  • Data Table on France - Market size and forecast 2024-2029 ($ million)
  • Chart on France - Year-over-year growth 2024-2029 (%)
  • Data Table on France - Year-over-year growth 2024-2029 (%)
• 12.14 Japan - Market size and forecast 2024-2029
  • Chart on Japan - Market size and forecast 2024-2029 ($ million)
  • Data Table on Japan - Market size and forecast 2024-2029 ($ million)
  • Chart on Japan - Year-over-year growth 2024-2029 (%)
  • Data Table on Japan - Year-over-year growth 2024-2029 (%)
• 12.15 Brazil - Market size and forecast 2024-2029
  • Chart on Brazil - Market size and forecast 2024-2029 ($ million)
  • Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
  • Chart on Brazil - Year-over-year growth 2024-2029 (%)
  • Data Table on Brazil - Year-over-year growth 2024-2029 (%)
• 12.16 South Korea - Market size and forecast 2024-2029
  • Chart on South Korea - Market size and forecast 2024-2029 ($ million)
  • Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
  • Chart on South Korea - Year-over-year growth 2024-2029 (%)
  • Data Table on South Korea - Year-over-year growth 2024-2029 (%)
• 12.17 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

• 13.1 Market drivers
• 13.2 Market challenges
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029
• 13.4 Market opportunities/restraints

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Abbott Laboratories
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key news
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Segment focus
  • SWOT
• 15.5 AbbVie Inc.
  • AbbVie Inc. - Overview
  • AbbVie Inc. - Product / Service
  • AbbVie Inc. - Key news
  • AbbVie Inc. - Key offerings
  • SWOT
• 15.6 Amgen Inc.
  • Amgen Inc. - Overview
  • Amgen Inc. - Product / Service
  • Amgen Inc. - Key news
  • Amgen Inc. - Key offerings
  • SWOT
• 15.7 AstraZeneca Plc
  • AstraZeneca Plc - Overview
  • AstraZeneca Plc - Product / Service
  • AstraZeneca Plc - Key news
  • AstraZeneca Plc - Key offerings
  • SWOT
• 15.8 Bayer AG
  • Bayer AG - Overview
  • Bayer AG - Business segments
  • Bayer AG - Key news
  • Bayer AG - Key offerings
  • Bayer AG - Segment focus
  • SWOT
• 15.9 Biogen Inc.
  • Biogen Inc. - Overview
  • Biogen Inc. - Product / Service
  • Biogen Inc. - Key offerings
  • SWOT
• 15.10 Boehringer Ingelheim International GmbH
  • Boehringer Ingelheim International GmbH - Overview
  • Boehringer Ingelheim International GmbH - Product / Service
  • Boehringer Ingelheim International GmbH - Key news
  • Boehringer Ingelheim International GmbH - Key offerings
  • SWOT
• 15.11 Eli Lilly and Co.
  • Eli Lilly and Co. - Overview
  • Eli Lilly and Co. - Product / Service
  • Eli Lilly and Co. - Key offerings
  • SWOT
• 15.12 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
  • SWOT
• 15.13 Horizon Therapeutics Plc
  • Horizon Therapeutics Plc - Overview
  • Horizon Therapeutics Plc - Product / Service
  • Horizon Therapeutics Plc - Key offerings
  • SWOT
• 15.14 Johnson and Johnson Services Inc.
  • Johnson and Johnson Services Inc. - Overview
  • Johnson and Johnson Services Inc. - Business segments
  • Johnson and Johnson Services Inc. - Key news
  • Johnson and Johnson Services Inc. - Key offerings
  • Johnson and Johnson Services Inc. - Segment focus
  • SWOT
• 15.15 Novartis AG
  • Novartis AG - Overview
  • Novartis AG - Business segments
  • Novartis AG - Key news
  • Novartis AG - Key offerings
  • Novartis AG - Segment focus
  • SWOT
• 15.16 OPKO Health Inc.
  • OPKO Health Inc. - Overview
  • OPKO Health Inc. - Business segments
  • OPKO Health Inc. - Key offerings
  • OPKO Health Inc. - Segment focus
  • SWOT
• 15.17 Pfizer Inc.
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Product / Service
  • Pfizer Inc. - Key news
  • Pfizer Inc. - Key offerings
  • SWOT
• 15.18 Sanofi SA
  • Sanofi SA - Overview
  • Sanofi SA - Business segments
  • Sanofi SA - Key news
  • Sanofi SA - Key offerings
  • Sanofi SA - Segment focus
  • SWOT

16 Appendix

• 16.1 Scope of the report
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations